Table 1:

Baseline characteristics of included participants with type 2 diabetes mellitus

CharacteristicTotal no. (%)of participants*
n = 10 251
No. (%) of male participants*
n = 6299
No. (%) of female participants*
n = 3952
p value
Lean BMI, mean ± SD; kg/m219.6 ± 2.9421.0 ± 2.6017.5 ± 2.05< 0.05
Fat mass index, mean ± SD; kg12.0 ± 4.029.97 ± 2.6815.2 ± 3.69< 0.05
Age, yr; mean ± SD62.8 ± 6.6563.0 ± 6.8162.6 ± 6.38< 0.05
Intensive glucose control5128 (50.0)3145 (49.9)1983 (50.2)0.8
Ethnicity< 0.05
 White6393 (62.4)4234 (67.2)2159 (54.6)
 Nonwhite3858 (37.6)2065 (32.8)1793 (45.4)
Median duration of diabetes, mean ± SD; yr10.8 ± 7.610.8 ± 7.6010.8 ± 7.60.8
Hypertension7726 (75.4)4630 (73.5)3096 (78.3)< 0.05
Hyperlipidemia7165 (69.9)4452 (70.7)2713 (68.6)< 0.05
Previous cardiac events3609 (35.2)2586 (41.1)1023 (25.9)< 0.05
Current smoker1429 (13.9)961 (15.3)468 (11.8)< 0.05
History of heart failure494 (4.8)309 (4.90)185 (4.7)0.3
Proteinuria2035 (19.9)1286 (20.4)749 (19.0)< 0.05
Depression2421 (23.6)1261 (20.0)1160 (29.4)< 0.05
Heart rate, mean ± SD; bpm72.7 ± 11.871.8 ± 11.974.1 ± 11.3< 0.05
Systolic blood pressure, mean ± SD; mm Hg136 ± 17.1135.6 ± 16.6137.5 ± 17.9< 0.05
Diastolic blood pressure, mean ± SD; mm Hg74.9 ± 10.774.6 ± 10.775.3 ± 10.6< 0.05
Glycated hemoglobin, mean ± SD; %8.30 ± 1.068.27 ± 1.048.34 ± 1.07< 0.05
GFR, mean ± SD; mL/min91.0 ± 27.290.9 ± 22.991.2 ± 32.80.6
FPG, mean ± SD; mg/dL175 ± 56.2176 ± 57.0174 ± 54.8< 0.05
Cholesterol, mean ± SD; mg/dL
 Total183 ± 41.9177 ± 40.1194 ± 42.4< 0.05
 Low-density lipoprotein104 ± 33.9101 ± 32.4111 ± 35.3< 0.05
 High-density lipoprotein41.9 ± 11.638.6 ± 9.6547.1 ± 12.6< 0.05
  • Note: BMI = body mass index, FPG = fasting plasma glucose, GFR = glomerular filtration rate, SD = standard deviation.

  • * Unless specified otherwise.